Coloplast A/S (CLPBY)
OTCMKTS · Delayed Price · Currency is USD
9.56
+0.15 (1.54%)
Oct 24, 2025, 3:59 PM EDT
Coloplast Market Cap
Coloplast has a market cap or net worth of $21.36 billion as of October 24, 2025. Its market cap has decreased by -25.68% in one year.
Market Cap
21.36B
Enterprise Value
25.02B
Revenue
4.39B
Ranking
n/a
PE Ratio
33.30
Stock Price
$9.56
Market Cap Chart
Since November 17, 1997, Coloplast's market cap has increased from 891.72M to 21.36B, an increase of 2,295.88%. That is a compound annual growth rate of 12.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 21.36B | -13.27% |
| Dec 30, 2024 | 24.63B | -4.23% |
| Dec 29, 2023 | 25.72B | 3.77% |
| Dec 30, 2022 | 24.79B | -33.55% |
| Dec 30, 2021 | 37.30B | 14.26% |
| Dec 30, 2020 | 32.65B | 23.84% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 806.69M |
| Elite Pharmaceuticals | 633.13M |
| Glass House Brands | 618.32M |
| Silence Therapeutics | 342.45M |
| Nika Pharmaceuticals | 335.28M |
| CytoDyn | 319.85M |
| Northwest Biotherapeutics | 305.00M |
| American Oncology Network | 297.14M |